BRIEF-Eli Lilly Says Intends To Make Bebtelovimab Commercially Available For Purchase By U.S. States/Territories, Through Sole Distributor From Aug. 15

BRIEF-Eli Lilly Says Intends To Make Bebtelovimab Commercially Available For Purchase By U.S. States/Territories, Through Sole Distributor From Aug. 15

Eli Lilly and Co:

* ELI LILLY SAYS INTENDS TO MAKE BEBTELOVIMAB COMMERCIALLY AVAILABLE FOR PURCHASE BY U.S. STATES/TERRITORIES, THROUGH SOLE DISTRIBUTOR FROM AUG. 15 Source text Further company coverage:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.